Off-label Drug Coverage

Off-Label Drug Coverage is a health insurance policy provision that determines reimbursement for pharmaceuticals prescribed in accordance with medically accepted indications not formally approved by regulatory authorities.

55

Publications

1.9K

Citations

214

Authors

123

Institutions

Publications per year

2017–2026

11

Authors

214

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    3 publications · 136 citations

    3

    h-index

  2. GC
    G. Caleb Alexander

    Johns Hopkins University, United States

    3 publications · 122 citations

    3

    h-index

  3. JA
    Jerry Avorn

    Brigham and Women's Hospital, United States

    3 publications · 136 citations

    3

    h-index

  4. JA
    Jonas A. de Souza

    University of Chicago, United States

    2 publications · 25 citations

    2

    h-index

  5. CP
    Colm P. O’Donnell

    University College Dublin, Ireland

    2 publications · 186 citations

    2

    h-index

1–5 of 214

Venues

  1. JAMA

    3 publications · 93 citations

    3

    h-index

  2. PubMed

    Repository · 3 publications · 88 citations

    3

    h-index

  3. Journal of Clinical Oncology

    2 publications · 92 citations

    2

    h-index

  4. PLoS ONE

    2 publications · 39 citations

    2

    h-index

  5. Internal Medicine Journal

    2 publications · 47 citations

    2

    h-index

1–5